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Abstract
Objective
Juvenile myoclonic epilepsy (JME) is supposedly the most frequent subtype of 
idiopathic generalized epilepsies (IGE). The aim of this study was to determine 
the prevalence of JME and comparison of patients’ demographics as well as 
timeline of the disease between positive family history epileptic patients (PFHE) 
and negative family history epileptic patients (NFHE) among sample of Iranian 
epileptic patients.
Materials & Methods
From Feb. 2006 to Oct. 2009, 1915 definite epileptic patients (873 females) 
referred to epilepsy clinics in Isfahan, central Iran, were surveyed and among 
them, 194 JME patients were diagnosed. JME was diagnosed by its specific 
clinical and EEG criteria. Patients were divided into two groups as PFHE and 
NFHE and data were compared between them.
Results
JME was responsible for 10% (194 patients) of all types of epilepsies. Of JME 
patients, 53% were female. In terms of family history of epilepsy, 40% were 
positive. No significant differences was found between PFHE and NFHE groups 
as for gender (P>0.05). Age of epilepsy onset was significantly earlier in PFHE 
patients (15 vs. 22 yr, P<0.001). Occurrence of JME before 18 yr old among 
PFHE patients was significantly higher (OR=2.356, P=0.007).
Conclusion
A family history of epilepsy might be associated with an earlier age of onset in 
patients with JME. 
Keywords: Epilepsy; Juvenile Myoclonic Epilepsy; Family history; Timeline; 
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Introduction
Millions of people are affected by epilepsy worldwide (1). Epilepsy, which involves 
recurrent seizures due to abnormal firing patterns of neurons within neuronal 
networks (2, 3), is described as a heterogeneous group of disorders caused by 
interactions between many genes and environmental factors (4).
Juvenile myoclonic epilepsy (JME) is a primary generalized epilepsy syndrome 
classified among the idiopathic generalized epilepsies (IGEs) in accordance with 
the International League against Epilepsy (ILAE) classification system (5). The 
family history of different types of epilepsy as a possible risk factor for JME is 
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reported, thus, suggesting probable genetic basis of JME 
(6, 7). JME among siblings suggests both polygenic 
and autosomal recessive mode of inheritance but is of 
controversial subject (6, 8).
Role of family history in time line of JME still remains 
unclear. However, the family history of epilepsy affected 
the timeline of the disease (9, 10). Furthermore there are 
no studies available to assess the role of family history 
of epilepsy (FHE) in JME among Iranian patients, and 
particularly on the timeline of JME.
The aim of this study was to comparison patients’ 
demographics and timeline of JME between positive 
family history epileptic patients (PFHE) and negative 
family history epileptic patients (NFHE). 
Materials & Methods
In this retrospective study, from Feb. 2006 to Oct. 
2009, 1915 definite epileptic patients (873 females 
and 1042 males) referred to epilepsy clinics in Isfahan, 
central Iran, among them, 194 JME patients were 
diagnosed. The diagnosis of JME was based on strict 
clinical and EEG features proposed by the ILAE (11). 
Electroencephalogram (EEG) pattern of myoclinic 
seizure shows a normal background with frequent 
generalized polyspike and wave discharges that may be 
anteriorly dominant or diffuse (By definition, polyspike 
and wave discharges have at least 3 spikelike components 
in them) (12).
The study design was approved by Ethics Committee of 
Isfahan University of Medical Sciences and all patients 
gave informed consent prior to take part in this trial.
Inclusion criteria were as follows: 1) Clinical evidence 
of generalized seizures of myoclonic jerks with or 
without absence seizures; 2) No proof of neurological or 
intellectual impairment; 3) More than one abnormality 
in EEG with generalized spike-wave or polyspike-wave 
(SW/PSW) discharges; and 4) Normal brain imaging 
(CT/MRI) if performed. 
Patients were excluded if encompassed the following 
criteria: 1) If a focal neurological or intellectual 
impairment were observed; 2) If there was an abnormality 
in imaging; 3) If myoclonic jerks was secondary to 
cerebral hypoxia, metabolic or degenerative diseases 
such as Alzheimer or Parkinson; 4) If JME developed 
to the generalized tonic-clonic seizure; 5) and if the data 
were incomplete. 
We divided our patients into two groups: PFHE and 
NFHE, based on the consanguinity information that the 
patients provided in the presence of their relative(s). 
First-degree relative was identified as being the mother, 
father, sibling or offspring of an epileptic patient. 
Parental consanguinity was determined as second-degree 
relative. Prevalence of FHE among JME patients as well 
as information about gender, age, age of epilepsy onset 
(age at the first seizure) were obtained by a neurologist 
expert and two mentioned groups were compared. 
Statistical analyses were carried out using SPSS, version 
20. (Chicago, IL, USA). To assess data analysis we 
applied independent t-test and chi-square test. P-value of 
less than 0.05 was considered as a statistically significant 
level.
Results
Overall, 1915 epileptic patients were assessed. Totally, 
194 (10%) JME patients were diagnosed, and 102 (53%) 
cases were female (Table 1).  Seventy-seven cases 
(40%) of JME patients were positive family history, 
58 (75%) had first-degree relatives and 19 (25%) had 
second degree relatives.
Regarding the gender, there were no significant 
differences between PFH and NFH patients (P>0.05). 
Age of patients was 26±14 yr (mean± s.d; Table 1), and 
age of JME onset was 19±15 yr. The age of epilepsy 
onset was significantly earlier in PFHE patients 
compared to NFHE patients (Table 1; 15±9 vs. 22±16 
yr, respectively; mean±.s.d; P<0.001).
Occurrence of JME prior to age of 18 yr among PFHE 
patients was significantly greater in comparison to 
NFHE patients (Table 2; OR=2.356, 95%-CI: 1.260–
4.408, P=0.007).
Discussion
Surveying epilepsy genetically has considerably 
contributed to our understanding of the basic mechanisms 
in epileptogenesis in addition to its diagnosis and therapy 
(4, 13-15). Therefore, a detailed analysis of family 
history is of great value in evaluating epileptic patients. 
In this retrospective study we investigated 1915 epileptic 
patients. The prevalence of JME among our epileptic 
patients was 10% (194 patients). Various percentages 
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age of epilepsy onset among patients with family history 
of epilepsy in comparison to patients without a family 
history (9). Another study investigated the age onset of 
seizure in patients with focal cortical dysplasia (FCD) 
showed that a family history of epilepsy was associated 
with an earlier age at seizure onset in patients with FCD 
(10). Our analysis shows that the age of JME onset was 
significantly earlier in PFHE patients compared to NFHE 
patients (15 vs. 22; respectively). In addition, occurrence 
of JME prior to age of 18 yr (before entering the adult), 
was approximately 2.3 fold greater in PFHE patients 
in comparison with NFHE patients. Thus, despite the 
impact of acquired factors in the occurrence of epilepsy 
(4), genetic factors are strong enough to change the 
timeline of the disease (39).
In this study, we did not investigate the relative with 
JME, separately; instead, we considered all types of 
epilepsy as a history of JME in relatives. Further studies 
required to evaluate the family history of JME in JME 
patients.
In conclusion, a family history of epilepsy is associated 
with an earlier age of onset in patients with juvenile 
myoclonic epilepsy, thus suggesting that the clinical 
presentation in these patients is affected by genetic 
predisposition.  
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for JME among all epilepsy types have been reported 
earlier (16-20). In large cohorts, JME prevalence was 
between 5-10% of all epilepsies (21). 
In this study, slight predominance of women was 
observed, as 53% vs. 47%. According to ILAE in 1989, 
distribution of JME between male and female was equal 
(22). However, recent reports present predominance 
of women in JME (23). A case series shows that 
approximately 60% of patients were women (24). 
Another population-based study also found that females 
outnumbered males with JME (25). These different 
percentages could be as a result of different population 
and different genetic basis of patients or maybe because 
of unknown role of sex hormones; however, further 
investigation is required.
Forty percent of our JME patients had FHE. In agreement 
our study, family history was reported in 20%-53% of 
JME patients (26-34). In Brasilia, history of epilepsy 
was in 53% JME patients (31). In Saudi Arabia, 48.7% 
prevalence of FHE was among JME patients (32). 
Recently, study carried out in Pakistan found 20% 
history of epilepsy in JME patients (29). These studies 
are presenting FHE in JME much more than most of other 
epilepsy types. These reports indicate the importance of 
family history in occurrence and prevalence of JME, 
led to significant genetic studies (30). On the other 
hand, JME has generalized idiopathic pattern. Previous 
findings strongly suggest the inheritance-underlying 
pattern for idiopathic epilepsies (27, 35). In addition, the 
association between generalized and idiopathic types of 
epilepsy has been mentioned in previous studies (27, 36). 
Thus, association between generalized and idiopathic 
types of epilepsy with genetic bases is probable reason 
for greater rate of PFHE among JME patients but 
probably this is not the only cause of higher value of 
FHE in JME.
Seizures can occur at any age, depending on risk factors 
such as sleep deprivation, structural brain abnormalities 
and particularly genetic factors (37, 38).  Yet, the role 
of FH in timeline of the JME is unclear. However, 
previous studies evaluated the role of FH in other types 
of epilepsy. For instance, some studies reported earlier 
age of onset for idiopathic and cryptogenic epilepsies in 
the presence of family history (27, 35). Similarly, in a 
retrospective study of 420 Saudi Arabian, found earlier 
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Table 1. Comparison between PFH Patients and NFH Patients: Patients’ Demographics and Age of Onset
Male Female Sum Age (yr) Age onset (yr)



























P>0.05 P>0.05 ----- <0.001 <0.001
PFH: patients with family history of epilepsy 
NFH: patients without family history of epilepsy
Table 2. Comparison between PFH Patients and NFH Patients: Occurrence of JME Under 18 Years Old
PFH NFH P-value Odds ratio PFH/NFH
Under 18 occurrence 58 64 0.007 2.356
After 18 occurrence 20 52 0.007 0.424
PFH: patients with family history of epilepsy 
NFH: patients without family history of epilepsy
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